Okay, let's tackle this question about the marker for granulocytic sarcoma. First, I need to recall what granulocytic sarcoma is. From what I remember, it's also known as a chloroma, right? It's a solid tumor composed of myeloblasts, which are immature myeloid cells. So the question is asking about the specific marker that's used to identify this condition.

The options aren't provided, but the user expects me to generate the correct answer and explain the reasoning. The correct answer is likely CD117 (c-KIT), which I think is the marker for mast cells and also for granulocytic sarcomas. Wait, but maybe other markers are involved too. Let me double-check. CD117 is a tyrosine kinase receptor and is commonly expressed in myeloid blasts. Another possibility is CD34, but that's more for B-cell lineage. CD15 is a granulocyte marker, but I think granulocytic sarcomas express CD15 as well. However, CD117 is more specific for the myeloid lineage and is used in diagnosing these tumors.

Wait, but I also recall that CD117 is part of the KIT family, which is involved in cell proliferation. In the context of myeloid tumors, especially AML with granulocytic sarcoma, CD117 would be present. So the correct answer is CD117.

Now, the other options: Let's think about what other markers are there. CD34 is for early B-cell and some myeloid cells, but not specific. CD15 is a granulocyte marker, present in some cases but not specific. CD1a is for Langerhans cells. CD45 is a leukocyte common antigen, present on all leukocytes. So the incorrect options would be these.

The core concept here is the immunohistochemical markers used to diagnose granulocytic sarcoma, which is a solid tumor formed by immature myeloid cells. CD117 is a key marker here. The clinical pearl would be to remember that CD117 (c-KIT) is crucial for diagnosing granulocytic sarcomas, and it's part of the myeloid lineage markers. Also, differentiating it from other tumors like mastocytomas, which also express CD117, but in the context of a myeloid blast, it's CD117.

**Core Concept**
Granulocytic sarcoma is a solid tumor composed of immature myeloid blasts (myeloblasts) and is associated with acute myeloid leukemia (AML). Its diagnosis relies on immunohistochemical markers that distinguish myeloid lineage from other blast types. **CD117 (c-KIT)** is a critical marker for these tumors, reflecting tyrosine kinase receptor activity in myeloid and mast cell lineages.

**Why the Correct Answer is Right**
**CD117 (c-KIT)** is a transmembrane tyrosine kinase receptor expressed on myeloblasts and mast cells. In granulocytic sarcoma, CD117 is highly specific for myeloid blasts, aiding differentiation from lymphoblastic or other tumors. It is also

✓ Correct Answer: C. CD117